Navigation Links
Lexicon to Provide First Quarter 2011 Financial Results
Date:4/26/2011

THE WOODLANDS, Texas, April 26, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that it will release its first quarter 2011 financial results on Tuesday, May 3, 2011 before the financial markets open.  Lexicon management will hold a conference call to discuss financial results for the quarter and program status at 11:00 a.m. Eastern Time that same day.  Lexicon will provide an in-depth update and in-depth review of its clinical pipeline at its upcoming R&D Day on May 12, 2011.

The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international).  The conference ID for all callers is 62216935.  An archived version of the conference call will be available on Lexicon's corporate website at www.lexpharma.com through May 31, 2011.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking" statements, including statements re
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
2. Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
3. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
4. Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
5. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
6. Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference
7. Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
8. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
9. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
10. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
11. Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... Sept. 29, 2011 A west coast secret is finally ... the way from Beverly Hills, California, a health and beauty ... ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is helping ... in less than 4 weeks of use.  Just a few ...
... Sept. 29, 2011 Terumo Americas Holdings, Inc., a ... anniversary of Terumo Corporation,s founding in 1921.  Terumo Corporation ... with $4 billion in annual sales and operations in ... Forbes magazine ranked Terumo Corporation 14th of the ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary 2Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary 3
(Date:4/24/2014)... and stressful outcomes for parents who have a child ... says a recent study led by a researcher at ... numerous and life-changing and stress levels high, the vast ... reported positive outcomes as well, a phenomenon known as ... issue of the American Journal of Orthopsychiatry . ...
(Date:4/24/2014)... 2014 ,Take me out to the ballgame, doesn,t ... chips. The more likely culprits include French fries, soda ... for children who play youth baseball, eating unhealthy food ... problems, according to researchers at Wake Forest Baptist Medical ... of Childhood Obesity , found that high-calorie snacks ...
(Date:4/24/2014)... will bring together national experts to discuss solutions ... inaugural Brain Health Summit, titled "The Human Brain: ... Dr. Sandra Bond Chapman, founder and chief director ... Grassley (R-IA), U.S. Representative Chaka Fattah (D-PA) and ... Early Learning, U.S. Department of Education. The day ...
(Date:4/24/2014)... and irrelevant, could offer an alternative to heart transplants ... Furtado, and her team from the Australian Regenerative Medicine ... fibroblast is a close relative to a cardiomyocyte, the ... research published today in Circulation Research , Dr ... due to their genetic program, and will aid in ...
(Date:4/24/2014)... opioid overdose deaths was outlined yesterday in the ... agencies in the U.S. Department of Health and Human ... to expand their use of medications to treat opioid ... of misperceptions that have limited access to these potentially ... be used in combination with behavior therapies to help ...
Breaking Medicine News(10 mins):Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Take the bat, leave the candy 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Boring cells could hold the key to heart disease 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4
... in laser skin treatments combines two radio frequency modes into one device. ... tighten skin by focusing laser on both shallow and deep tissue depths. ... by New York,s Juva Skin and Laser Center. , ... New York, ...
... treatment for ... Germany,s 300,000 physicians, ISMANING, Germany, Nov. ... SMY), a leading provider of solutions,that open the Digital World, ... program: the eHealth500 mobile terminal., The eHealth500 mobile terminal ...
... York, NY, November 13, 2008Compared to patients in seven ... are far more likely to forgo care because of ... errors, coordination problems, and high out-of-pocket costs, according to ... as a Web Exclusive in the journal Health ...
... from thousands of members, SEIU officials shut down,California ... 12 Caregivers who work in,California hospitals, nursing ... and Oakland offices of their national union, the ... members of United Healthcare Workers-West (UHW), a,local union ...
... following is a,statement by Larry Minnix, President & CEO, ... "We applaud Senator Baucus for releasing a health care ... alignment with our Five Big,Ideas to transform aging services. ... and technology in its efforts to,determine how our health ...
... Operating Former Conseco Senior,Health Insurance Company Long-Term ... Policyholders, HARRISBURG, Pa., Nov. 12 ... that it has approved the,separation, effective today, ... Conseco Senior Health Insurance Company) ("SHIP"),from Conseco, ...
Cached Medicine News:Health News:Accent Dual Mode Skin Tightening Laser is Latest Offering from Juva Skin Center 2Health News:SCM Microsystems Introduces New Mobile Terminal for the German Electronic Health Card 2Health News:SCM Microsystems Introduces New Mobile Terminal for the German Electronic Health Card 3Health News:New survey: More than half of US chronically ill adults skip needed care due to costs 2Health News:New survey: More than half of US chronically ill adults skip needed care due to costs 3Health News:New survey: More than half of US chronically ill adults skip needed care due to costs 4Health News:New survey: More than half of US chronically ill adults skip needed care due to costs 5Health News:Healthcare Workers Picket Their National Union to Protect Their Voice for Patients 2Health News:Statement From Larry Minnix, President & CEO, American Association of Homes and Services for the Aging on the Release of Sen. Baucus's Health Care Reform Proposal 2Health News:Pennsylvania Insurance Department Approves Launch of Senior Health Care Oversight Trust 2
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
Medicine Products: